Tag Archives: Treated

Perinatal Anxiety: Common But Not Frequently Recognized or Treated

According to a recent meta-analysis published in the Journal of Clinical Psychiatry, one in five pregnant women experience at least one type of anxiety disorder. While this may be surprising to some, anybody who works with pregnant and postpartum women is well aware that anxiety is very common in this population.   Because anxiety is so… Read More »

FDA Grants Genentech’s Polivy (polatuzumab vedotin-piiq) Accelerated Approval for Adults With Previously Treated Aggressive Lymphoma

Print this page South San Francisco, CA — June 10, 2019 — Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Polivy (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan (rituximab) (BR) for the treatment of adults with relapsed or refractory (R/R)… Read More »